B
Bull
Bull · 25%GYRO
$9.32
Szenariopreis
$5.180
-0.010 (-0.19%)Zum Schluss
Loading chart…
- High
- 5.250
- Open
- 5.250
- VWAP
- 5.20
- Vol
- 1.93K
- Mkt Cap
- 17.88M
- Low
- 5.180
- Amount
- 10.05K
- EV/EBITDA, TTM
- 0.00
Gyrodyne, LLC owns and manages diverse commercial properties. The Company’s primary business is the management of a portfolio of medical office and industrial properties and the pursuit of entitlements on such properties located in Suffolk (Flowerfield) and Westchester (Cortlandt Manor) Counties, New York. The Company owns about a 63-acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York. In Cortlandt Manor, New York, the Company owns about 13.8 acres inclusive of the 31,421-square-foot Cortlandt Medical Center.
AI analysis of Gyrodyne LLC (GYRO)
sellGyrodyne LLC is not a good buy right now due to its significant decline in price and weak financial indicators. The current price is $5.18, which is down 42.83% year-to-date and 49.17% over the past year. Additionally, the RSI is at 28.494, indicating that the stock is oversold, but this could also suggest a continued downward trend. The forward P/E ratio is 0, which reflects a lack of earnings growth expectations, and the current ratio has dropped to 0.44, indicating potential liquidity issues. The main risk is the declining equity, which fell to $25,924,002 in the latest quarter, suggesting financial instability.
Bewertungskennzahlen
The current forward P/E ratio for Gyrodyne LLC (GYRO) is 0.00, compared to its 5-year average forward P/E of 0.00.
Alphio AI Price Scenarios for GYRO
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Event-Zeitleiste
News
4.509-08BenzingaRobinhood Shares Surge Over 7%; Check Out 20 Stocks Making Moves in Premarket Trading
8.508-04NewsfilterGYRODYNE, LLC ANNOUNCES AGREEMENT TO SELL 49-ACRE PARCEL IN SMITHTOWN, NEW YORK AS PART OF STRATEGIC LIQUIDATION PLAN
8.508-04BenzingaWhy CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
- 7.010-16Newsfilter
New York Supreme Court Rules in Favor of Gyrodyne in Article 78 Proceeding
GYRO FAQ — answered by Alphio AI
Gyrodyne, LLC owns and manages diverse commercial properties. The Company’s primary business is the management of a portfolio of medical office and industrial properties and the pursuit of entitlements on such properties located in Suffolk (Flowerfield) and Westchester (Cortlandt Manor) Counties, New York. The Company owns about a 63-acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York. In Cortlandt Manor, New York, the Company owns about 13.8 acres inclusive of the 31,421-square-foot Cortlandt Medical Center. It operates in the Real Estate sector (OPERATORS OF NONRESIDENTIAL BUILDINGS industry).
Gyrodyne LLC is not a good buy right now due to its significant decline in price and weak financial indicators. The current price is $5.18, which is down 42.83% year-to-date and 49.17% over the past year. Additionally, the RSI is at 28.494, indicating that the stock is oversold, but this could also suggest a continued downward trend. The forward P/E ratio is 0, which reflects a lack of earnings growth expectations, and the current ratio has dropped to 0.44, indicating potential liquidity issues. The main risk is the declining equity, which fell to $25,924,002 in the latest quarter, suggesting financial instability.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.